Defining pre-cancerous potential of Persistent Rhombic Lip (PeRL) to develop biomarkers for Group 3/4 Medulloblastoma 2023 ASPIRE Award Sriram Venneti, MD, PhD, University of Michigan, Ann Arbor; Michael Taylor, MD, PhD, Texas Children's Hospital; Elaine Mardis, PhD, Nationwide Children's Hospital Read More
Understanding the role of KMT2D in MLL-AF9 acute myeloid leukemia 2023 Damon Runyon - Mark Foundation Physician-Scientist Nicole Cruz, MD, The Rockefeller University Read More
Chemical Hijacking of E3 Ligases for the Selective Targeting of Oncogenic mTOR Signaling 2023 ASPIRE Award Cristina Mayor-Ruiz, PhD; Antoni Riera Escalé, PhD, Institute for Research in Biomedicine (IRB Barcelona), Spain; Alejo Efeyan, PhD, Centro Nacional de Investigaciones Oncológicas (CNIO), Spain Read More
Exploiting Protein Structural Dynamics for New Uveal Melanoma Therapies 2023 ASPIRE Award Aashish Manglik, MD, PhD; Michelle Arkin, PhD; Boris Bastian, MD, PhD, University of California, San Francisco Read More
Chemical Repair of an Oncogenic Mutation in p53 2023 ASPIRE Award Nir London, PhD, The Weizmann Institute of Science, Israel Read More
Lessons from Ancient Mechanisms of Tumor-Host Interactions 2023 ASPIRE Award David Bilder, PhD, University of California, Berkeley Read More
